Hence, a single-cell sequencing cohort of primary breast cancer (GSE75688) was used to analyze NRF2 expression differences between immune (T cells, B cells, and myeloid cells), tumor, and stromal cells. Here, NFE2L2 is linked to breast carcinoma.